Location History:
- Daejon, KR (2011)
- Daejeon, KR (2011 - 2014)
Company Filing History:
Years Active: 2011-2014
Title: Nahmryune Cho: Innovator in Pharmaceutical Chemistry
Introduction
Nahmryune Cho is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel piperazine compounds. With a total of 3 patents to his name, Cho's work focuses on innovative solutions for mental health treatment.
Latest Patents
Cho's latest patents include groundbreaking research on phenyl piperazine compounds. These compounds are designed to bind effectively to the Serotonin 1A (5-HT1A) receptor, which plays a crucial role in the treatment and prevention of depression and anxiety. His inventions not only encompass the compounds themselves but also the pharmaceutical compositions that utilize these compounds for therapeutic purposes. The methods he has developed aim to treat various conditions related to the 5-HT1A receptor in mammals.
Career Highlights
Throughout his career, Nahmryune Cho has worked with notable companies such as SK Holdings Co., Ltd. and SK Biopharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Cho has collaborated with talented individuals in his field, including Yonggil Kim and Yunhee Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Nahmryune Cho stands out as an influential inventor in the pharmaceutical industry. His innovative work on piperazine compounds has the potential to significantly impact the treatment of mental health disorders. His contributions continue to pave the way for advancements in pharmaceutical chemistry.